AKTIP and rheumatoid arthritis: As previous studies imply that the main mechanism of action of FTS is down modulation of the T cell response (36), and the major role of T cells in AIA pathogenesis (42), we chose this pre-clinical model to assess the therapeutic potential of FTS in human RA.